Paper Details

  1. Home
  2. Paper Details

Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta-analysis.

Author: BianchiAlberto, KawadaTatsushi, KimuraTakahiro, LaukhtinaEkaterina, MajdoubMuhammad, MoriKeiichiro, MostafaeiHadi, PallaufMaximilian, PradereBenjamin, QuhalFahad, RajwaPawel, Sari MotlaghReza, ShariatShahrokh F, ShimSung Ryul, YanagisawaTakafumi, von DeimlingMarkus

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study looks at the effectiveness of different treatments for prostate cancer in patients with poor performance status, including high-risk non-metastatic, metastatic hormone-sensitive, and non-metastatic/metastatic castration-resistant prostate cancer.
Paper Details　
Original Abstract of the Article :
To evaluate the efficacy of systemic therapies in patients with worse performance status (PS) treated for high-risk non-metastatic prostate cancer (PCa), metastatic hormone-sensitive PCa (mHSPC), and non-metastatic/metastatic castration-resistant PCa (nmCRPC/mCRPC), as there is sparse pooled data sh...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/bju.16106

データ提供：米国国立医学図書館（NLM）

Performance Status: A Key Factor in Prostate Cancer Treatment

Prostate cancer is a common and complex disease, with treatment options varying based on the stage and aggressiveness of the cancer. This study investigates the impact of performance status (PS), a measure of a patient's overall health, on the effectiveness of systemic therapies for prostate cancer. The researchers conduct a meta-analysis, pooling data from multiple studies to explore the relationship between PS and treatment outcomes in patients with different stages of prostate cancer.

Performance Status: Guiding Treatment Decisions for Prostate Cancer

This research reveals that performance status plays a crucial role in determining the effectiveness of systemic therapies for prostate cancer. The study highlights the importance of considering PS when making treatment decisions, tailoring treatment approaches to the individual patient's overall health and fitness.

Performance Status: A Personalized Approach to Prostate Cancer Treatment

This research underscores the need for a personalized approach to prostate cancer treatment, taking into account the individual patient's performance status. It highlights the importance of considering a range of factors, including health, fitness, and other potential complications, when developing a treatment plan.

Dr.Camel's Conclusion

Like a camel navigating a challenging and ever-changing desert, this research emphasizes the importance of considering performance status when choosing the right path for prostate cancer treatment. The study highlights the need to tailor treatment decisions to each patient's unique health profile, ensuring the most effective and personalized approach to combat this complex disease.

Date :
  1. Date Completed 2023-09-22
  2. Date Revised 2023-09-22
Further Info :

Pubmed ID

37395151

DOI: Digital Object Identifier

10.1111/bju.16106

Related Literature

Article Analysis
・Effects of darolutamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.